Myosin Drives Retrograde F-Actin Flow in Neuronal Growth Cones  by Lin, C.H et al.
Neuron, Vol. 16, 769±782, April, 1996, Copyright 1996 by Cell Press
Myosin Drives Retrograde F-Actin Flow
in Neuronal Growth Cones
C. H. Lin,* E. M. Espreafico,² M. S. Mooseker,³ the leading edge, followed by retrograde translocation
and recycling at a proximal site by filament severingand P. Forscher³
and/or disassembly. This process was referred to as*National Yang-Ming University
ªretrograde flowº (Forscher and Lin, 1991, J. Cell Biol.,Taipei, Taiwan
abstract; Forscher and Smith, 1988; Mitchison and²Department of Morphology
Kirschner, 1988; Smith, 1988; see also Figure 6B).Faculdade de Medicina de RibeiraÄ o Preto-USP, SP
The peripheral actin ultrastructure of the growth coneBrazil
has also been well characterized, being composed of³Department of Biology
two distinct structural domains: filopodia containingYale University
arrays of uniformly polarized (barbed end distal) actinNew Haven, Connecticut 06511
filaments, and intervening lamellipodium domains with
less polarized filament structure (cf. Figure 6A; Lewis
and Bridgman, 1992). Both domains appear to exhibitSummary
uniform retrograde flow relative to an external substrate
reference, as judgedby actin fluorescence photobleach-Actin filaments assembled at the leading edge of neu-
ing studies (Lin and Forscher, 1995). Assembly of actinronal growth cones are centripetally transported via
filaments, followed by centripetal displacement relativeretrograde F-actin flow, a process fundamental to
to the leading cell margin, has been observed in a widegrowth cone guidance and other forms of directed cell
variety of motile cells, and appears to be a fundamentalmotility. Here we investigated the role of myosins in
property of directed growth processes and cell migra-retrograde flow, using two distinct modes of myosin
tion (Cramer et al., 1994; Bray and White, 1988; Wang,inhibition: microinjection of NEM inactivated myosin
1985; Fisher et al., 1988; Abercrombie et al., 1970).S1 fragments, or treatment with 2,3-butanedione-2-
In our initial characterization of actin filament dynam-monoxime, an inhibitor of myosin ATPase. Both treat-
ics in Aplysia growth cones, we noted that when conesments resulted in dose-dependent attenuation of re-
were treated with cytochalasin, retrograde flow did nottrograde F-actin flow and growth of filopodia. Growth
appear to be markedly affected. Continued retrogradewas cytochalasin sensitive and directly proportional
flow in the absence of new actin assembly resulted into the degree of myosin inhibition, suggesting that
formation of an F-actin-free gap along the growth coneretrograde flow results from superimposition of two
margin, and eventual clearance (typically in z3 min) ofindependent processes: actin assembly and myosin-
F-actin from lamellipodia and filopodia. This persistent
based filament retraction. These results provide the
retraction of actin filament networks in the absence of
first direct evidence for myosin involvement in neu-
actin assembly demonstrated that polymerization couldronal growth cone function.
not be supplying the driving force for retrograde F-actin
flow; therefore, we suggested that a myosin-like molecu-
lar motor might be involved (Forscher and Smith, 1988).
Introduction Despite recent molecular cloning of several brain myo-
sins (Bahler et al., 1994; Ruppert et al., 1993; Cheney et
Neuronal growth cones guide axons in the developing al., 1993) and localization of myosins to growth cones
nervous system toward distant target sites. Recent evi- (Rochlin, 1995; Espreafico et al., 1992; Cheng et al.,
dence suggests that growth cones decode both diffus- 1992; Miller et al., 1992), little or no information regarding
ible and substrate-bound molecular signals during the functional role of myosins in growth cone motility
the guidance process (Kennedy and Tessier-Lavigne, has emerged to date (cf. Tanaka, 1995).
1995; Tessier-Lavigne, 1992) that involves pathfinding, Given the functional implications of our previous work,
branching, and ultimately, targetrecognition. All of these we designed experiments aimed at global inhibition of
behaviors depend on precise regulation of growth cone myosin activity, to test whether any myosin was in fact
motility. Bray pioneered investigation of growth cone involved in driving retrograde F-actin flow in growth
motility and was the first to observe that inert particles cones. All known myosins have an evolutionarily con-
placed on the growth cone surface moved in a retro- served N terminal head domain containing the ATP,
grade direction, suggestive of an underlying centripetal F-actin-binding, and force generation sites (Mooseker
membrane or actin filament flux (Bray, 1970). Early stud- and Cheney, 1995). Chymotryptic digestion of muscle
ies also demonstrated that growth cone motility de- myosin results in cleavage of a head domain subfrag-
pended on actin filament assembly (Yamada and Wes- ment (S1) from the rest of the molecule (Margossian and
sells, 1973), and a critical role for actin assembly in Lowey, 1982). S1 exhibits ATP-dependent actin filament
axonal guidance emerged when it was shown that axons binding, but lacking the C terminal tail, is incapable of
in the developing grasshopper nervous system lost all generating force unless artificially tethered (e.g., by an
pathfinding capabilities when treated with cytochalasin antibody) to a substrate. In addition, further treatment of
(Bentley et al., 1986). Later, studies characterizing actin S1 with the sulfhydryl reagent, N-ethylmaleimide (NEM),
dynamics in Aplysia growth cones in vitro suggested results in a myosin head species (NEM-S1) that remains
that the retrograde flux mentioned above was actually tightly bound to actin filaments, even in the presence
of ATP, and thus can serve as a potent specific inhibitordue to actin filament assembly at nucleation sites along
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The S1 proteins prepared for microinjection were fur-Table 1. ATP-Dependent F-Actin Interactions with S1 and
ther characterized by Western blot analysis (Figure 1A)NEM-S1
and immunofluorescence on cultured neurons (FigureS1 NEM-S1
1B). Whenresolved by SDS-PAGE and stained with Coo-
ATP (2 mM) 2 1 2 1 massie Brilliant blue, purified S1 or NEM-S1 subfrag-
Percent Protein cosedimented 95 6 1 7 6 1 81 6 8 75 6 3 ment preparations contained one major z100 kDa pro-
with actin filaments
tein (Figure 1A, lanes 1 and 3). A monoclonal antibody,
F59, against thehead domain of vertebrate skeletal mus-
cle myosin-II, recognized this major protein and twoof actomyosin function (Cande, 1986; Meeusen and
other minor lower molecular weight species (lanes 2Cande, 1979). Our first experimental approach was then
and 4, Figure 1A); the latter are likely due to limitedto competitively inhibit myosin function by injection of
proteolysis of the S1 and NEM-S1 proteins; their con-purified S1 or NEM-S1, and look at effects on growth
centrations were less than one tenth that of the z100
cone motility, actin dynamics, and structure.
kDa protein species. In addition, Western blot analysis
We then compared these results with those obtained
of Aplysia CNS (lanes 5 and 6, Figure 1A) and immuno-
after treatment, with 2,3-butanedione-2-monoxime
fluorescence of uninjected cultured Aplysia neurons
(BDM), a pharmacological inhibitor of endogenous myo-
(data not shown) with the F59 antibody resulted in es-
sin ATPase activity. BDM has previously been shown to
sentially no immunoreactivity, indicating that endoge-
effect cross-bridge kinetics and inhibit both conven-
nous Aplysia myosins were not recognized by F59.
tional muscle and nonmuscle myosin ATPases, includ-
Myosin antagonists were typically microinjected into
ing myosin V, platelet myosin II, and a drosophila myosin
the cell body (arrow, Figure 1B), along with rhodamine-
ATPase fraction, without affecting kinesin ATPase activ-
dextran (10±40 kDa) as a volume indicator. Microin-
ity or actin assembly (Backx et al., 1994; Cramer and
jection of S1 or NEM-S1 proteins resulted in characteris-
Mitchison, 1995; McKillop et al., 1994; Schramm et al., tic structural and functional effects on the peripheral
1994; Zhao and Kawai, 1994). We show here that both growth cone lamella (Figure 1). These effects were asso-
types of myosin inhibition result in essentially the same ciated with the presence of exogenous myosin proteins
effects: attenuation of retrograde F-actin flow accompa- in the cell body and the growth cone region (dashed
nied by filopodial, and leading edge extension at rates box, Figure 1B) of the injected cell, as evidenced by
directly proportional to the degree of flow inhibition. positive labeling with the F59 antibody. Growth cones
These experiments suggest that simple superimposi- used for injection studies were typically <50 mm away
tion of two additive processes: actin polymerization, from the cell body, to facilitate rapid diffusion into the
and the action of myosin motors underlie retrograde growth cone region. Control injections of buffer alone
F-actin flow. or rhodamine-dextran resulted in no obvious effects on
growth cone motility or structure (data not shown). A
Results typical example of the effects of S1 microinjection is
shown in Figures 1C±1E. Progressive elongation of filo-
Structural and Functional Changes Induced podia was observed (white arrowheads; Figures 1C±1D)
by S1 or NEM-S1 Microinjection 3 min after injection of S1 protein. Rhodamine-phalloidin
Table 1 summarizes the results of F-actin cosedimenta- staining revealed a high concentration of actin filaments
tion assays performed on S1 and NEM-S1 preparations. in these newly extended filopodia (Figure 1E).
S1 bound to F-actin in the absence but not in the pres- NEM-S1 injection resulted in similar effects; however,
ence of ATP. The ATP-dependent release of S1 from NEM-S1 was more potent and its effects reversed more
F-actin was nearly abolished by NEM-modification. slowly than S1, as expected from the cosedimentation
These results are consistent with previous reports on results. Under control conditions or immediately after
NEM-modified heavy meromyosin (Meeusen and microinjection, the ruffling transition zone was typically
Cande, 1979). In control experiments where S1 or NEM- situated between the peripheral lamelipodium and the
S1 proteins were centrifuged in the absence of actin central microtubule-rich cytoplasmic domain (Forscher
filaments 6 ATP, no protein was detected in the pellet and Smith, 1988).Within z30 s of NEM-S1microinjection
injection, filopodia extended over time (Figure 1F, openfraction (data not shown).
Figure 1. Effects of S1 and NEM-S1 Microinjection on Aplysia Growth Cones
(A) Western blot analysis using F59 monoclonal antibody. Purified S1 (lanes 1 and 2), NEM-S1 (lanes 3 and 4), and protein preparation from
whole Aplysia nervous tissue (lanes 5 and 6) were either stained with Coomassie Brilliant blue (lanes 1, 3, and 5) or probed with F59 antibody
(lanes 2, 4, and 6).
(B) S1 (or NEM-S1) protein was microinjected at the cell body (arrow). Injected protein revealed by F59 immunofluorescence; growth cone
region: dashed box.
(C and D) S1 subfragments at concentration of 7.9 mg/ml were injected into the cell shown at lower magnification in (B). DIC images of the
growth cones taken before (C) and 3 min after microinjection (D). Note filopodia elongation (arrowheads).
(E) Extended filopodia (arrowheads) contain actin filaments, as revealed by rhodamine-phalloidin staining (identical fields: [D], [E]).
(F) Analysis of growth dynamics following NEM-S1 (2.9 mg/ml) microinjection. Note the initial progressive elongation of filopodia (open
arrowheads) and subsequent retraction (closed arrowhead). Expansion of ruffling domain (asterisks) was also apparent. Time (in s) after
microinjection is indicated. Bar represents 5 mm.
(G) Retrograde F-actin flow is attenuated after NEM-S1 microinjection. Retrograde flow rates before and after microinjection of either rhodamine-
dextran control vehicle) or4.2 mg/ml NEM-S1 were measured using flow-coupled bead markers. Time 5 0 min indicates NEM-S1 microinjection.
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Table 2. Dose Dependence of Retrograde F-Actin Flow Attenuation by NEM-S1
Control NEM-S1
NEM-S1* (mM) Retrograde Flow (mm/min) % Control Rate Average
1.2 113.00 85.80 75.93
113.00 96.00 84.96 80.44 6 6
1.9 113.00 94.70 83.81
90.00 84.30 93.67
90.00 76.00 84.44 87.31 6 6
2.3 80.00 56.50 70.63
85.30 50.80 59.55 65.09 6 8
2.8 113.00 88.00 77.88
90.00 68.00 75.56
76.00 35.00 46.05
85.30 56.20 65.89 66.34 6 19
3.4 83.50 24.00 28.74
80.00 34.60 43.25
85.30 49.00 57.44 43.15 6 14
4.9 83.50 24.80 29.70
113.00 47.00 41.59 35.65 6 8
* assuming z1/10 cell volume injections.
Flow rates 5 mean 6 SD
arrowheads), and the ruffling transition zone often ap- injection of NEM-S1 resulted in rapid dose-dependent
peared to expand outward (Figure 1F, white asterisks). attenuation of retrograde flow (NEM-S1; Figure 5D); the
Initial rates of extension appeared similar for all filopodia retrograde flow rate decreased to 1.16 6 0.61 mm/min
within a given growth cone. In this example, the filopo- between 1±6 min after injection, and spontaneously re-
dium indicated (white arrowheads) elongated during the covered to 4.47 6 1.01 mm/min after z7 min. Table 2
first 105 s after injection, then shortened somewhat be- and Figure 5D show dose-response data for NEM-S1
tween 105±150 s (closed arrowhead). The duration of injection experiments. Cellular NEM-S1 concentrations
elongation varied, ranging from 1±10 min (N 5 17 experi- were estimated assuming z1/10 cell volume injections.
ments), resulting in filopodia of different lengths. These
effects tended to reverse spontaneously over time; how-
ever, filopodia shortening appeared to be much slower, Pharmacological Inhibition of Myosin
occurring in a less synchronous manner than initial filo- Activity Mimics S1 Microinjection
podium elongation. Growth cones of NEM-S1 injected To further investigate the effects of myosin inhibition on
cells often exhibited leading edge extension; however, growth cones, we treated cells with BDM, a myosin
the degree of extension tended to vary along the extent ATPase inhibitor. BDM treatment resulted in similar ef-
of the leading edge, with more pronounced advance fects to those observed after S1 or NEM-S1 microinjec-
typically occurring toward the front of the growth cone. tion: attenuation of retrograde flow accompanied by
In NEM-S1 experiments where extension of filopodia rapid growth. Figure 2A demonstrates typical effects of
and leading edge occurred simultaneously, the extent BDM treatment, including progressive filopodium elon-
of outgrowth was always more robust in filopodia than gation (arrowheads), leading edge extension (arrows),
the leading edge (data not shown). Actin filament net- and a slight retraction of the central cytoplasmic do-
work geometry may be playing a role here; since filo-
main. Note the net widening of the lamellipodium during
podia contain unidirectional actin filaments oriented
BDM treatment. In the continuous presence of BDM,
parallel with the direction of growth whereas lamelli-
leading edge and filopodial advance typically continuedpodia are characterized by a less-polarized filament or-
for 5±10 min, then gradually stopped, despite persistentganization, filopodial protrusion driven by actin assem-
attenuation of retrograde flow.bly may be more efficient.
BDM treatment also resulted in dose-dependent at-The structural effects of NEM-S1 microinjection were
tenuation of retrograde F-actin flow (Figure 2B). Maximalaccompanied by attenuation of retrograde F-actin flow.
depth of flow attenuation occurred about 4 min afterTo measure F-actin flow rates, we utilized membrane-
drug application (Figure 2B, shaded bars), and persistedbound flow-coupled beads previously demonstrated to
as long as the drug was present. Retrograde flow recov-be reliable noninvasive markers for quantitating actin
ered to control levels 5±6 min after BDM washout. Tablenetwork dynamics in this system (Lin and Forscher,
3 and Figure 5D show dose-response data pooled by1995). Beads were rapidly positioned in the desired area
normalizing flow rates measured 4 min after drug addi-of interest using a laser trap, and average bead translo-
tion by the control flow rates. Overall, BDM effects oncation rates were measured before and after NEM-S1
both structure and motility were strikingly similar toinjection. A typical example is shown in Figure 1G. Con-
those observed after either S1 or NEM-S1 injections (cf.trol flow rates before microinjection were 5.90 6 0.79
Figure 1).mm/min (mean 6 SEM), and no significant change
Structural effects of BDM on the growth cone cyto-(5.37 6 1.18 mm/min) was observed in cells microin-
jected with rhodamine-dextran alone (vehicle).However, skeleton were further examined by visualization of
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Figure 2. Pharmacological Myosin Inhibition
Mimics Effects of NEM-S1 Microinjection
(A) DIC image sequence of a growth cone
before (Control) and during treatment with 30
mM BDM. Note the progressive filopodia
elongation (arrowheads) and the concomitant
leading edge extension (arrows). Asterisk in-
dicates a bead on the substrate for reference.
Sampling interval per panel 5 15 s. Bar repre-
sents 5 mm.
(B) BDM treatments attenuate retrograde
F-actin flow. Note that flow attenuation ap-
pears to be dose-dependent, and growth
cone exhibits complete recovery after drug
washout.
Table 3. Dose Dependence of Retrograde F-Actin Flow Attenuation by BDM
Control BDM
BDM (mM) Retrograde Flow (mm/min) % # Control Rate Average
1 6.04 6 0.47 (22)# 6.10 6 0.56 (26) 101
4.68 6 0.35 (21) 4.55 6 0.49 (20) 97 91 6 8
6.15 6 0.41 (16) 5.24 6 0.43 (25) 85
3.98 6 0.38 (16) 3.27 6 0.41 (18) 82
5 3.88 6 0.39 (20) 2.94 6 0.26 (19) 76
4.95 6 0.42 (23) 3.66 6 0.39 (21) 74 70 6 5
6.15 6 0.44 (16) 4.14 6 0.42 (27) 67
4.36 6 0.39 (15) 2.80 6 0.34 (19) 64
10 3.20 6 0.27 (9) 2.07 6 0.29 (22) 65
4.99 6 0.34 (20) 3.19 6 0.38 (39) 64
4.93 6 0.36 (18) 2.93 6 0.26 (25) 59 56 6 8
3.32 6 0.29 (13) 1.84 6 0.28 (24) 55
4.37 6 0.38 (21) 1.60 6 0.25 (23) 37
30 3.85 6 0.33 (16) 1.86 6 0.25 (18) 48
6.21 6 0.45 (14) 2.47 6 0.29 (14) 40
5.23 6 0.40 (19) 1.99 6 0.26 (20) 38 32 6 12
5.80 6 0.46 (26) 1.01 6 0.33 (25) 17
4.37 6 0.38 (21) 0.76 6 0.21 (18) 17
50 5.47 6 0.44 (17) 1.08 6 0.26 (18) 20
3.04 6 0.23 (6) 0.55 6 0.27 (19) 18
5.16 6 0.33 (10) 0.93 6 0.36 (24) 18 15 6 4
4.93 6 0.29 (19) 0.49 6 0.18 (16) 10
4.26 6 0.30 (15) 0.37 6 0.17 (15) 9
Flow rates 5 mean 6 SD # 5 Number of flow calculations done
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F-actin and tubulin arrays by fluorescence microscopy Filopodium Extension and Retrograde F-Actin
Flow Rates Are Inversely Proportional(Figure 3). Over time, filopodia tended to elongate and
Since myosin inhibition resulted in simultaneous attenu-accumulate F-actin. In contrast, microtubule distribution
ation of retrograde F-actin flow and filopodium exten-appeared to be relatively unperturbed even after pro-
sion, we investigated how these two phenomena werelonged BDM treatments. There also appeared to be a
related. To quantitate F-actin movement, flow coupledgradual proximal to distal depletion of actin filaments
bead markers were positioned with a laser trap at thein lamellipodia.
same location on the lamellipodium before and after
myosin inhibition treatments, as in Figures 5A±5C. Note
BDM or S1/NEM-S1 Induced Extension in this example that under control conditions, retrograde
Depends on Actin Polymerization flow (Figure 5B, black vector, rate 5 5.10 mm/min) is
Filopodium and leading edge extension observed fol- accompanied by essentially no filopodium extension
lowing myosin inhibition could result either from actin (white dashed line). Two min after application of 10 mM
assembly or translocation of preexisting actin filaments. BDM, retrograde flow decreased to about 54% of the
To differentiate between these two mechanisms, we control rate (Figure 5C, black vector, rate 5 2.75 mm/
used cytochalasin B (CB) to inhibit barbed end actin min) and filopodium extension occurred (white dashed
polymerization during BDM (Figure 4A), or S1 microin- line, rate 5 2.21 mm/min). Similar data analyses were
jection (data not shown) induced filopodium elongation. performed on growth cones treated with different con-
As shown in Figure 4A, filopodium elongation was first centrations of BDM (Figure 5E, open circles, 29 experi-
triggered by BDM treatment (white line, 0±40 s). Subse- ments) or microinjected with 2±4 mg/ml NEM-S1 that
quently, exposure to 1mM CB in the presence of BDM translates into intracellular protein concentrations of 2±4
immediately eliminated further filopodium extension mM assuming a z1/10 cell volume injections (Figure 5E,
(dashed line, 50±90 s). Finally, washout of CB in the closed squares, 17 experiments). Retrograde flow rates
presence of BDM resulted in resumption of filopodial decreased with either increasing BDM dose or amount
extension at nearly pre-CB rates (black line, 100±150 s). of NEM-S1 protein injected (Figure 5D). When the dose-
These results indicate that barbed end actin assembly response data from both types of inhibitor studies were
drives the protrusive growth observed during BDM treat- pooled and filopodium growth plotted against retro-
ments and S1/NEM-S1 microinjections. grade F-actin flow rates, an inverse linear relationship
was apparent, strongly suggesting that filopodia growth
and retrograde flow are simple additive processes withActin Network Translocation during Cytochalasin
opposite sign (Figure 5E).Treatment Is Myosin-Dependent
Our previous work demonstrated a characteristic pat-
Discussiontern of persistent retrograde actin network retraction
during cytochalasin treatment (described above and in
Myosin(s) Drives Retrograde F-Actin Flow
Forscher and Smith, 1988; Lin and Forscher, 1993), sug-
in Neuronal Growth Cones
gesting that the translocation aspect of retrograde flow
In this study, we present two independent lines of evi-
did not depend on actin assembly. To examine the role
dence that retrograde F-actin flow in growth cones is
of myosin in this response, we observed the effects of driven by a myosin-type molecular motor: competitive
BDM treatment on F-actin network movement in the inhibition by injection of purified S1 or NEM inactivated
absence of actin assembly. Since the onset of BDM myosin head domain subfragments (NEM-S1), and phar-
effects are slower than CB (z3.0 versus z0.25 min re- macological inhibition of myosin ATPase activity with
spectively), growth cones were pretreated with BDM to BDM. Both treatment regimes resulted in strikingly simi-
attenuate retrograde flow before addition of CB (Figure lar effects on growth cone motility and structure, specifi-
4B, note nonlinear time points shown in individual pan- cally, dose-dependent attenuation of retrograde F-actin
els, asterisks). After 1 min in 30 mM BDM, filopodium flow accompanied by marked filopodial, and in the case
elongation was apparent (Figure 4B, 2 min, arrowhead) of BDM, leading edge growth. The significance of each
and substantial slowing of retrograde flow was ob- of these effects will be examined below.
served. At this point, CB was added and combined CB/ Both S1 and NEM-S1 compete with endogenous myo-
BDM treatment resulted in slow retraction of F-actin sin(s) for actin filament binding sites, and can thus be
from the leading edge (bars indicate F-actin free gap used as tools for studying actomyosin function. Because
formation). Note that retraction rates in CB/BDM were NEM-S1 binds actin filaments essentially irreversibly, it
very slow in the 2±5 min interval, and then stalled com- should be a more potent competitive antagonist as was
pletely during the 5±9 min interval. This 4 min stall period observed here. In contrast with the S1 or NEM-S1protein
is significant since under control conditions, it typically reagents that directly interact with actin filaments, evi-
takes less than 3 min for a filament at the leading margin dence suggests that BDM is a general myosin ATPase
to transverse the entire lamellipodium. At 9 min, myosin inhibitor (Cramer and Mitchison, 1995; Higuchi and Ta-
inhibition was relieved by BDM wash out and resulted kemori, 1989; Schramm et al., 1994; Steinen et al., 1995).
in retraction of residual actin networks (9±13 min). Note BDM is thought to act by stabilizing the weak actin-
that retraction resumed (in CB) at 4.85 mm/min, which binding myosin-ADP´Pi intermediate state (Herrmann et
is similar to retrograde flow rates observed under control al., 1992) and has seen wide used in muscle physiology
conditions (Forscher and Smith, 1988). The growth cone (Alpert et al., 1989; Fryer et al., 1988; Gwathmey et al.,
1992; Horiuti et al., 1988; Steele and Smith, 1993; Tungfully recovered after CB washout (20 min recovery).
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Figure 3. Changes in Cytoskeletal Structure after BDM
Cells were treated with 10 mM BDM for: 5, 15, and 30 min. F-actin structures (left) of the growth cone were revealed by rhodamine-phalloidin
staining and microtubule distribution (right) by b-tubulin immunofluorescence. Dotted lines in b-tubulin panels indicate leading edges of the
individual growth cones. Bar represents 10 mm.
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Figure 4. Actin Assembly and Myosin Motors Drive Independent Processes
(A) Actin assembly drives filopodium protrusion. Initial application of 10 mM BDM triggers filopodium elongation (0±40 s) at 5.6 mm/min.
Elongation was reversibly inhibited by adding 1 mM cytochalasin B (CB) to the BDM solution (50±90 s). Washout of the CB in the continuous
presence of BDM results in resumed outgrowth of the stalled filopodium at 4.62 mm/min (100±140 s). Time intervals for the sequence 5 10 s.
Bar represents 2 mm.
(B) Mysoin drives actin network retraction in the presence of CB. Pretreatment with 30 mM BDM resulted in filopodium elongation (black
arrowhead). After 1 min in BDM, 5 mM CB was added. Combined CB/BDM treatment induced gap formation as a result of breakaway of
F-actin from the leading edge (black line, 3 min CB/BDM). Retraction of residual actin networks was initially very slow, and later stopped
completely (5±9 min CB/BDM interval). Washout of BDM in the presence of CB resulted in retraction of residual actin networks (black line,
11±13 min CB). Full recovery was observed after CB washout (20 min recovery). Images shown are indicated by asterisks in experimental
protocol timeline. Bar represents 10 mm.
et al., 1985; West and Stephenson, 1989), where, not side effects? A parallel concern with competitive inhibi-
tors is that although their site of action may be specific,surprisingly, it acts as a relaxant.
A major concern with pharmacological agents such secondary effects may be incurred by displacement of
proteins other than the targeted effector molecule; foras BDM is specificity of action: are there contaminating
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Figure 5. Rates of Filopodium Growth and Retrograde F-Actin Flow Are inversely Proportional
(A) To compare the rates of F-actin flow before and after treatments that inhibited myosin activity, 200 nm beads were positioned at the same
location (box) using the laser trap. Bar represents 5 mm.
(B) Robust retrograde F-actin flow (black dashed line) and little, if any, filopodium outgrowth (white dashed line) were observed under control
conditions.
(C) After application of 10 mM BDM, filopodium elongation (white dashed line) occurred along with slowing of retrograde F-actin flow (black
dashed line). Bar represents 1 mm.
(D) Dose-response curves for NEM-S1 and BDM treatments. Rates are % control retrograde flow. See Tables 2 and 3 for details.
(E) Rates of filopodium elongation versus retrograde flow. Data from different experiments (growth cones) were normalized by control retrograde
flow rates.
example, NEM-S1 might displace actin binding proteins both were working through a common effector, i.e., my-
osin(s).involved in regulation of actin dynamics and/or network
structure. In this study, we found that both types of High concentrations (>50 mM) or long term (>30 min)
BDM treatments were accompanied by progressive de-myosin inhibition scheme (S1/NEM-S1 or BDM treat-
ment) led to nearly identical structural changes and ef- creases of F-actin content in lamellipodia (Figure 3). In
addition, although retrograde flow was inhibited as longfects on growth cone motility. This occurred despite the
disparate mechanisms of action embodied by the two as the BDM was present (Figure 2B), filopodia extension
occurred predominantly in the first 15 min after drugtreatments. It is highly unlikely that we would observe
such similar effects from such dissimilar agents unless application. These observations raise the issue of BDM
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side effects on actin metabolism. Cramer and Mitchison actin filaments and the acto-S1 complexes appear to
function as hyperstable actin nucleation sites (Miller et(1995) have recently shown that overnight treatment with
20 mM BDM had no effect on in vitro actin assembly, al., 1988). This property of S1 does not really affect our
interpretation of the effects of S1/NEM-S1 on retrogradeand we show here that filopodial protrusion induced by
10 mM BDM was due to continued barbed end assembly flow; however, it does raise the possibility that the filo-
podial growth we observe might be simply due to poten-(Figure 4A). These observations make it unlikely that the
decreased flow rates we observed shortly after BDM tiation of actin assembly by S1 orNEM-S1. As mentioned
above,BDM has little orno effect on in vitro actin assem-treatment resulted from actin related side effects. We
also noted that the ED50 for BDM mediated retrograde bly (Cramer and Mitchison, 1995), yet BDM treatment
consistently led to robust leading edge and filopodialflow attenuation was slightly higher than that recently
reported for inhibition of postmitotic spreading in PtK2 extension (e.g., Figure 2A). Although we can not rule out
permissive effects of S1 or NEM-S1 on actin assembly,cells (Cramer and Mitchison, 1995). This difference likely
reflects lower BDM solubility in the high salt marine the simple inverse proportionality of the growth versus
flow plot for bothBDM and NEM-S1 (Figure 5E) suggestssaline (ASW) used here than in the lower ionic strength
PBS used in the PtK2 study. that the major initial effect of both treatments is simply
slowing of retrograde flow that leads to proportionalFinally, the pattern of F-actin signal decay over time
after BDM treatment that can be seen in Figure 3 is filopodial growth. Finally, why BDM would elicit leading
edge growth more reliably than S1/NEM-S1 injectionsworth a short comment. Under control conditions retro-
grade flow delivers actin filaments to the proximal transi- is not clear. One possibility is that lamellipodia are more
easily disrupted than filopodia by agents (like S1 ortion zone at a rate of z100 nm/s (Mitchison and
Kirschner, 1988; Smith, 1988). To maintain steady state, NEM-S1) capable of interfering with actin cross linking
proteins.the growth cone must take apart or ªrecycleº these net-
works approximately as fast as they arrive (cf. Figure Do myosin motors or actin assembly limit the rate of
retrograde flow? A flow-coupled bead will move steadily6B). It is likely that this filament recycling involves sev-
ering and a yet uncharacterized accelerated disassem- rearward over time, and is not affected by nearby leading
edge and filopodia protrusions and retractions (P. F. andbly process, since it is too fast to be accounted for
by simple actin disassembly rates measured in vitro C. H. L., unpublished data). This supports the contention
that protrusion (assembly) and retrograde flow are un-(Pollard, 1986; Pollard and Cooper, 1986). In any case,
the anterograde spreading decay of lamellar F-actin coupled processes, and also that actin assembly rates
can transiently exceed those of retrograde flow. Thatover time we observe might result from continued action
of the filament recycling process in the absence of retro- actin assembly can drive motility at rates in excess of
retrograde flow was independently demonstrated dur-grade flow.
ing previous characterization of a focal actin assembly
response, triggered by highly charged polycationic
Actin Assembly Drives Protrusion and Myosin beads applied to the growth cone surface (Forscher et
Drives Retrograde Flow Independently al., 1992). In this case, actin assembly led to generation
Both S1/NEM-S1 and BDM treatments resulted in mod- of F-actin tails similar to those formed by invasive bacte-
erate leading edge extension and marked filopodial ria such as Listeria monocytogenes (Theriot et al.,
growth (Figures 1±3) that was totally and reversibly in- 1992b). We showed that actin assembly could drive
hibited by low doses of cytochalasin (Figure 4), demon- bead translocation at up to four times the average retro-
strating that protrusive growth can be accounted for by grade flow rate. Thus, it seems fairly clear that actin
barbed end actin filament assembly without invoking assembly rates do not limit retrograde flow, and further
alternative mechanisms, such as actin filament sliding. studies on myosin regulatory mechanisms in growth
In addition, we found that retrograde movement of (re- cones appear to be in order.
sidual) actin networks in CB was reversibly inhibited by
BDM (Figure 4B), indicating that in the absence of actin
assembly, retrograde movement of F-actin depends Significance of the Inverse Growth Versus
Retrograde Flow Relationshipcritically on myosin motor action, as originally proposed
(Forscher and Smith, 1988). These complimentary ex- Aplysia growth cones exhibit a spatially uniform pattern
of retrograde F-actin flow and advance very slowly whenperiments demonstrate that protrusive growth and re-
trograde flow are experimentally separable processes, they are not interacting with target substrates (Lin and
Forscher, 1995). Although the naming convention mayand suggest that the respective underlying mechanisms
of actin assembly and myosin powered network retrac- differ, a wide variety of motile cells also exhibit centripe-
tal flux, cortical flow, or retrograde flow of F-actin. De-tion are independent. If the latter suggestion were true,
growth and retrograde flow would be expected to be spite its ubiquitous presence and speculations regard-
ing its importance, the mechanism of retrograde flowadditive processes of opposite sign; i.e., they would be
inversely proportional. Indeed, when filopodial growth has been elusive (Bray and White, 1988; Cramer et al.,
1994; Heath and Holifield, 1991). The results of the pres-was plotted versus retrograde flow under varying de-
grees of myosin inhibition, an inverse linear relationship ent study help fill this gap in our knowledge, and suggest
a surprisingly simple steady state model can accountwas readily apparent (Figure 5). It should also be noted
here that previous studies have shown that S1 can pro- for the salient features of the retrograde flow. Since both
filopodial and lamellipodial F-actin (Figure 6A) appearmote actin assembly in vitro (Grazi et al., 1980; Detmers
et al., 1981). S1 exhibits 1:1 stochiometric binding to to move in concert (Lin and Forscher, 1995), we treat
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them as a single kinetic unit and make the simplifying
assumptions depicted inFigure 6B.Under controlcondi-
tions, we observe slow growth and robust retrograde
flow; actin filaments are moved away from the leading
edge by myosin action about as fast as they are assem-
bled (Figure 6B, control). Whenmyosin is inhibited, retro-
grade flow slows and we observe growth in direct pro-
portion to the degree of flow attenuation (Figure 6B,
myosin inhibited). Note that this ªgrowthº involves a net
widening of the peripheral domain (cf. Figure 2A), and
thus differs markedly from the physiological growth we
observe during growth cone target interactions (Lin and
Forscher, 1993). In the latter case, synchronous and
directed advance of both central microtubule and pe-
ripheral lamellar domains is observed, enabling the
growth cone to maintain structural equilibrium, despite
dramatic increases in its net growth rate.
In contrast with growth cones, which at best advance
relatively slowly, cells such as keratocytes can translo-
cate approximately as fast as actin is assembled at their
leading margin; therefore, although constant centripetal
actin flux in the cell's reference frame occurs, there is
little or no retrograde F-actin flow, with respect to an
external substrate reference (Theriot and Mitchison,
1991; Theriot and Mitchison, 1992a). It is thought that
keratocytes and other highly motile cells employ highly
efficient adherence mechanisms to limit actin slippage
and thereby keep retrograde flow to a minimum (Lee et
al., 1993; Lee et al., 1994). Interestingly, we have recently
shown that when growth cones interact with a favorable
growth substrate, retrograde flow slows in directpropor-
tion to increased rates of both leading edge and axonal
microtubule advance (Lin and Forscher, 1995). We sus-
pect that in this case, flow attenuation results from stabi-
lization of newly assembled actin filaments, with respect
to the target substrate by adhesion complexes that may
act somewhat like a molecular clutch (Lin et al., 1994;
Tanaka, 1995). Note this would not only promote the
protrusive growth observed, but in the context of the
present study would appear to engage the actomyosin
force generation system, perhaps allowing the growth
cone to pull the distal axon toward the target substrate.
In the context of directed axonal growth, it is interest-
ing to note that the central domain appeared to recede
slightly during myosin inhibition experiments (cf. Figure
2A), and microtubule distribution did not appear to be
markedly affected (Figure 3). This kind of response is
tors. Motors are bound to a reference frame stable with respect
to an external substrate reference (shaded box). Extracellular flow
coupled beads move in synchrony with retrograde F-actin flow (gray
arrow). Newly assembled F-actin is shaded. Myosin Inhibition atten-
uates both retrograde flow and bead movement resulting in protru-
sive growth due to maintained F-actin assembly. Rates of growth
and retrograde F-actin flow are inversely proportional.
Figure 6. Model (C) Generation of centripetal force could be accomplished by the
(A) Major structural domains of a growth cone are the microtubule- action of conventional (A) or nonconventional (B) myosins either
rich central domain and F-actin-rich peripheral domain comprised intercalated into less ordered actin networks and acting through a
of unipolar barbed (1) end distal actin filaments (filopodium) and less local network contraction mechanism, or alternatively, by interacting
polarized intervening cross-linked networks in the lamellipodium. with the polarized filopodial actin filament arrays. Possible myosin
(B) Simplified schematic of myosin inhibition results. Under Control localization to microtubules in the central cytoplasmic domain could
conditions, filopodial length is maintained by actin assembly at the promote microtubule tensioning and directed advance ([C], dis-
leading margin balanced by retrograde flow driven by myosin mo- cussed in text).
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Forscher, 1995). 2,3-butanedione-2-monoxime (Sigma, St. Louis,very unusual in this system. Nearly all perturbations of
MO) was dissolved in DMSO before adding to ASW, such that thegrowth cone function we have previously encountered
final concentration of DMSO in working solutions was less thanincluding prolonged cytochalasin treatment (cf. Figures
0.3%. In control experiments, no effects on growth cone structure or
4 and 7; Forscher and Smith, 1988), aging in culture, motility were observed after 1% DMSO treatment (data not shown).
exposure to phototoxic light levels, osmotic shock, and
perturbation of actin structure by various pharmacologi- Microinjection
The microinjection protocol was described previously (Lin andcal agents, result in microtubule extension, rather than
Forscher, 1995). Briefly, bag cell neurons were transferred to a cus-recession. An intriguing possibility suggested by these
tom-made injection chamber, then the cell bodies were impaledobservations is that actomyosin interactions in the
with a glass pipette mounted on a 3D hydraulic micromanipulator
growth cone promote microtubule extension either by (Narashigi USA) retrofitted with a piezoelectric axial drive (Burleigh
tensioning microtubules or by a less direct mechanism Instruments, Fishers, NY) under video-enhanced-DIC observation.
(cf. Figure 6C). Clearly, this would be advantageous dur- Purified S1 or NEM-S1 proteins at concentrations of 2±8 mg/ml
were loaded in the injection needle together with 0.5 mg/ml 10 kDaing growth cone target interactions when highly directed
rhodamine-dextran (Molecular Probes Incorporated, Eugene, OR)microtubule advance is observed (Lin and Forscher,
used as a volume indicator. Reagent or vehicle solution injections1993).
were typically z10% of cell volume.
These results provide the first functional evidence that
myosin motors are involved in generating retrograde Immunoblots and Immunofluorescence
flow in growth cones. Given the structural makeup of For fluorescent staining of the cytoskeleton, cells were first fixed
F-actin in the growth cone, the force generation mecha- with 4% freshly made paraformaldehyde in isotonic ASW supple-
mented with 400 mM sucrose (pH 7.6) (Lin and Forscher, 1993).nism might involve localized activation and contraction
After fixation, cells were permeabilized for 2±5 min in fixation bufferof myosin molecules intercalated into the less-ordered
plus 0.5% Triton- 3 X 0, washed with PBS, and stained with rhoda-lamellar actin networks, or myosins interacting with the
mine-phalloidin (Molecular Probes) in PBS. Cells were then washed
unipolar actin filament arrays in filopodia (Figure 6C). with PBS, exposed to 5% bovine serum albumin-PBS, followed by
The functional implications of this study provide a strong monoclonal mouse anti-b-tubulin antibody (Sigma, St. Louis, MO),
impetus for further molecular characterization of the my- washed with PBS, exposed to FITC conjugated goat anti-rabbit
secondary antibody (Jackson Labs, West Grove, PA), washed withosin(s) involved, and suggest a conceptual framework
PBS, transferred to a mounting solution containing PBS supple-for understanding and testing the role of retrograde actin
mented with 20 mM n-propyl-gallate (Sigma) and 80% glycerol/20%flow in other motile systems.
PBS, and examined immediately. To localize microinjected S1 or
NEM-S1 proteins, F59, a monoclonal antibody made against the
Experimental Procedures head domains of skeletal muscle myosin (provided by Dr. Frank
Stockdale, Stanford University) was used. Culture supernatant from
Preparation of Proteins
the hybridoma cell line was diluted 1:50 for primary antibody incuba-
Skeletal muscle myosin was purified from chicken pectoralis mus-
tion. For immunoblot analysis, purified S1 and NEM-S1 proteins or
cle, according to the method of Kielley and Harrington (1959). Actin
wholeprotein preparation from Aplysia nervous tissue were resolved
was purified from an acetone powder of chicken skeletal muscle,
on a 5%±16% SDS-PAGE gel, transferred to nitrocellulose paper,according to the method of Spudich and Watt (1971). S1 proteolytic
and then probed with F59 monoclonal antibody at 1:250 dilutionfragments were prepared from myosin digested with 50 mg/ml
and secondary antibody conjugated with alkaline phosphatase.
a-chymotrypsin in the presence of 1 mM EDTA-K (Margossian and
Lowey, 1982); protease activity was inhibited by addition of 1 mM
Surface Markers and Micro-PositioningPefabloc (Boheringer Mannheim, Indianapolis, IN). NEM-S1 was pro-
To prepare flow-coupled beads for retrograde flow rate measure-duced by incubating S1 at 5±10 mg/ml in 50 mM KCl, 20 mM imida-
ment, 200±500 nm polystyrene beads (Polyscience, Warrington, PA)zole-Cl (pH 7.2), 1 mM EDTA-K, and 0.1 mM DTT, with 1.0 mM
or silica beads (Bangs Laboratory Incorporated, Carmell, IN) werefreshly dissolved NEM at room temperature for 20 min. The reaction
either coated with polyethyleneimine (Sigma; Forscher and Smith,was stopped by adding DTT to a final concentration of 10 mM;
1990; Lin and Forscher, 1995) or derivatized with avidin followedunreacted NEM was removed by dialysis (Meeusen and Cande,
by biotinylated Concanavalin A (Vector Laboratory Incorporated,1979). Cytochalasin B (CB) and BDM were purchased from Sigma
Burlingame, CA). Beads were then incubated for 10 min in artificialChemical Company (St. Louis, MO).
sea water (ASW) supplemented with 1 mg/ml BSA blocking protein
before application to cells to inhibit possible triggering of subjacentF-Actin Cosedimentation Assay
F-actin assembly by beads (inductopodia formation, see ForscherG-actin at a final concentration of 250 mg/ml (6 mM) was induced
et al., 1992). An infrared single beam gradient optical trap (Svobodato polymerize by addition of KCl to a final concentration of 75 mM
and Block, 1994) was used to repeatedly position beads at the sameand MgCl2 to 2.5 mM in a 10 mM imidazole, 1 mM EGTA buffer. S1
location on the growth cone lamella before and after treatmentsor NEM-S1 at a final concentration of 150 mg/ml (1.5 mM) were then
inhibiting myosin activity. The laser trap employed a 150 mW laseradded to the F-actinsolution either in the absence or in the presence
diode emitting at 790 nm, as previously described (Lin and Forscher,of 2 mM Mg-ATP. As controls, reactions containing only S1 or NEM-
1995).S1 without F-actin, or F-actin alone, were also performed. The reac-
tions were incubated at room temperature for 20 min, then centri-
Kinetic Analysis of Retrograde F-Actin Flowfuged at 100,000 X g for 45 min at 158C. Equal amounts of the
Kinetic analysis was done using programs developed in this labora-resulting supernatants and pellets were resolved on a 5%±16%
tory (Forscher et al., 1992; Lin and Forscher, 1993; Lin and Forscher,SDS-PAGE and then stained with Coomassie Brilliant blue. The gel
1995). To quantitate the changes in retrograde F-actin flow, flow-was then scanned and digitized using a Scanmaker III (Microtek
coupled beads were placed over the entire angular extent of theLaboratory Incorporated, Redondo Beach, CA), and densitometry
growth cone lamella before and after S1 or NEM-S1 microinjectionwas performed using Band Leader (Internet ShareWare, Ma'ayan
orBDM treatment. Translocation rates of individual beads (indicativeAharoni). Average values are shown in Table 1 from three experi-
of underlying F-actin flow rates) were measured during bead trans-ments using three separate protein preparations.
port on the lamella between the leading edge and the proximal
transition zone using 5 s sampling intervals. Data was pooled fromCell Culture, Solutions, and Video Microscopy
all beads attached to the growth cone membrane at any given timeCell culture and video microscopy techniques as previously de-
scribed (Forscher and Smith, 1988; Lin and Forscher, 1993; Lin and point; resulting average rates were then plotted as a function of time.
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To analyze correlations between the retrograde flow and structural move particles on the surface of a neuronal growth cone. In Optical
Microscopy for Biology. (New York: Wiley-Liss), pp. 459±471.changes (e.g., filopodium elongation), flow-coupled beads were po-
sitioned at the same site before and after the treatment using the Forscher, P., Lin, C.-H., and Thompson, C. (1992). Novel form of
laser trap. Bead centroid positions were obtained and used to calcu- growth cone motility involving site-directed actin filament assembly.
late the bead displacement (Lin and Forscher, 1995). Nature 357, 515±518.
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